Applied Therapeutics Stock In The News

APLT Stock  USD 0.59  0.05  9.26%   
Our overall analysis of Applied Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Applied Therapeutics. The specific impact of Applied Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Applied Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Applied Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Applied Therapeutics Backtesting and Applied Therapeutics Hype Analysis.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Applied Therapeutics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
ROSEN, A TRUSTED AND LEADING LAW FIRM, E...
https://www.globenewswire.com/news-release/2025/01/31/3018521/673/en/ROSEN-A-TRUSTED-AND-LEADING-LAW-FIRM-Encourages-Applied-Therapeutics-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-APLT.html
 Neutral
Macroaxis News: globenewswire.com
APLT INVESTOR ALERT: Kirby McInerney LLP...
https://www.globenewswire.com/news-release/2025/01/30/3018397/937/en/APLT-INVESTOR-ALERT-Kirby-McInerney-LLP-Notifies-Applied-Therapeutics-Inc-Investors-of-Upcoming-Lead-Plaintiff-Deadline-in-Class-Action-Lawsuit.html
 Neutral
Macroaxis News: globenewswire.com
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – APLT
https://www.globenewswire.com/news-release/2025/01/30/3018314/3080/en/Applied-Therapeutics-Inc-Sued-for-Securities-Law-Violations-Investors-Should-Contact-Levi-Korsinsky-for-More-Information-APLT.html
 Neutral
Macroaxis News: globenewswire.com
Bragar Eagel & Squire, P.C. Reminds Inve...
https://www.globenewswire.com/news-release/2025/01/30/3017676/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Capri-Applied-Therapeutics-Nextracker-and-Transocean-and-Encourages-Investors-to-Contac.html
 Neutral
Macroaxis News: globenewswire.com
APLT INVESTOR ALERT: Bronstein, Gewirtz ...
https://www.globenewswire.com/news-release/2025/01/29/3017555/9788/en/APLT-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-Applied-Therapeutics-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html
 Neutral
Macroaxis News: globenewswire.com
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact The Gross Law Firm about pending Class Action - APLT
https://www.globenewswire.com/news-release/2025/01/29/3017477/0/en/Shareholders-that-lost-money-on-Applied-Therapeutics-Inc-APLT-should-contact-The-Gross-Law-Firm-about-pending-Class-Action-APLT.html
 Neutral
Macroaxis News: globenewswire.com
DEADLINE ALERT for MGPI, APLT, and KSPI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
https://www.globenewswire.com/news-release/2025/01/29/3017444/0/en/DEADLINE-ALERT-for-MGPI-APLT-and-KSPI-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html
 Neutral
Macroaxis News: globenewswire.com
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
https://www.globenewswire.com/news-release/2025/01/29/3017346/683/en/DEADLINE-REMINDER-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Applied-Therapeutics.html
 Bullish
Macroaxis News: globenewswire.com
APLT COURT ALERT: The Applied Therapeutics Class Action Deadline is Approaching – Contact BFA Law before February 18 (NASDAQ:APLT)
https://www.globenewswire.com/news-release/2025/01/29/3017166/0/en/APLT-COURT-ALERT-The-Applied-Therapeutics-Class-Action-Deadline-is-Approaching-Contact-BFA-Law-before-February-18-NASDAQ-APLT.html
 Bullish
Macroaxis News: globenewswire.com
Lead Plaintiff Deadline Approaching in A...
https://www.globenewswire.com/news-release/2025/01/27/3016012/0/en/Lead-Plaintiff-Deadline-Approaching-in-APLT-Kessler-Topaz-Meltzer-Check-LLP-Reminds-Investors-A-Securities-Fraud-Class-Action-Has-Been-Filed-Against-Applied-Therapeutics-Inc-APLT.html
 Neutral

Applied Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Applied and other traded companies coverage with news coverage. We help investors stay connected with Applied headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on Applied Stock performance. Please note that trading solely based on the Applied Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Applied Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Applied Therapeutics investors visualize upcoming and past events in order to time the market based on Applied Therapeutics noise-free hype analysis.
Applied Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Applied earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Applied Therapeutics that are available to investors today. That information is available publicly through Applied media outlets and privately through word of mouth or via Applied internal channels. However, regardless of the origin, that massive amount of Applied data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Applied Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Applied Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Applied Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Applied Therapeutics alpha.

Applied Largest EPS Surprises

Earnings surprises can significantly impact Applied Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-09
2022-09-30-0.48-0.40.0816 
2024-03-06
2023-12-31-0.23-0.34-0.1147 
2023-08-10
2023-06-30-0.26-0.37-0.1142 
2019-08-12
2019-06-30-0.49-0.6-0.1122 
2023-05-11
2023-03-31-0.31-0.180.1341 
2021-08-12
2021-06-30-1.13-0.990.1412 
View All Earnings Estimates

Applied Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Applied Therapeutics Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
30th of January 2025
Levi Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and...
at news.google.com 
Google News at Macroaxis
27th of January 2025
Franklin Resources Inc. Reduces Stake in Applied Therapeutics Inc. - GuruFocus.com
at news.google.com 
Gurufocus Stories at Macroaxis
17th of January 2025
APLT INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Applied Therapeutics, ....
at gurufocus.com 
Gurufocus Stories at Macroaxis
15th of January 2025
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Applied Therapeutics, Inc. ...
at gurufocus.com 
Gurufocus Stories at Macroaxis
13th of January 2025
APLT CLASS ACTION NEWS Applied Therapeutics, Inc. ...
at gurufocus.com 
Yahoo News
8th of January 2025
Is Applied Therapeutics the Best Penny Stock to Invest In According to Media
at finance.yahoo.com 
prnewswire News
7th of January 2025
Applied Therapeutics, Inc. Investors Who Lost Money Have Opportunity to Lead Securities Fr...
at prnewswire.com 
Gurufocus Stories at Macroaxis
3rd of January 2025
Applied Therapeutics, Inc. Class Action Investors are Alerted the Company has been Sued fo...
at gurufocus.com 
Gurufocus Stories at Macroaxis
27th of December 2024
APLT Investor Alert A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied...
at gurufocus.com 
Gurufocus Stories at Macroaxis
20th of December 2024
ROSEN, A LEADING LAW FIRM, Encourages Applied Therapeutics, Inc. ...
at gurufocus.com 

Applied Therapeutics Investors Sentiment

The influence of Applied Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Applied. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Applied Therapeutics' public news can be used to forecast risks associated with an investment in Applied. The trend in average sentiment can be used to explain how an investor holding Applied can time the market purely based on public headlines and social activities around Applied Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Applied Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Applied Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Applied Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Applied Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Applied Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Applied Therapeutics' short interest history, or implied volatility extrapolated from Applied Therapeutics options trading.

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.